Literature DB >> 29358280

Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1.

Jonathan H DeLong1, Aisling O'Hara Hall2, Christoph Konradt1, Gaia M Coppock1,3, Jeongho Park1, Gretchen Harms Pritchard4, Christopher A Hunter5.   

Abstract

Ly6C and Sca-1 (Ly6A/E) are Ly6 family GPI-anchored surface molecules that are differentially expressed by multiple immune populations. Ly6C expression has been used to distinguish short-lived effector CD4+ T cells from memory precursor effector cells, whereas Sca-1 has been used in the identification of CD8+ memory stem cells. This study examines the expression patterns of these molecules and establishes that, in vitro, IL-27, type I IFN, and IFN-γ are potent inducers of Ly6C and Sca-1 in naive mouse CD4+ and CD8+ T cells, whereas TGF-β limits their expression. The induction of Ly6C and Sca-1 by IL-27 and IFN-γ is dependent on STAT1, but not STAT3 or T-bet. In mouse splenocytes, at homeostasis, Ly6C and Sca-1 expression was not restricted to effector cells, but was also found at various levels on naive and memory populations. However, in response to infection with Toxoplasma gondii, pathogen-specific T cells expressed high levels of these molecules and in this context, endogenous IL-27 and IFN-γ were required for the expression of Ly6C but not Sca-1. Together, these findings highlight the TCR-dependent and cytokine-mediated signals that modulate T cell expression of Ly6C and Sca-1 in vitro and in vivo during infection.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29358280      PMCID: PMC5821564          DOI: 10.4049/jimmunol.1701154

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Authors:  Ivan D Mascanfroni; Ada Yeste; Silvio M Vieira; Evan J Burns; Bonny Patel; Ido Sloma; Yan Wu; Lior Mayo; Rotem Ben-Hamo; Sol Efroni; Vijay K Kuchroo; Simon C Robson; Francisco J Quintana
Journal:  Nat Immunol       Date:  2013-09-01       Impact factor: 25.606

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  IL-27 renders DC immunosuppressive by induction of B7-H1.

Authors:  Svetlana Karakhanova; Tanja Bedke; Alexander H Enk; Karsten Mahnke
Journal:  J Leukoc Biol       Date:  2011-02-23       Impact factor: 4.962

4.  Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells.

Authors:  Xiaotong Zhu; Zhihao Liu; Jin-Qing Liu; Jianmin Zhu; Jianchao Zhang; Jonathan P Davis; Jianhong Chu; Jianhua Yu; Jie Zhou; Ming-Song Li; Xue-Feng Bai
Journal:  J Leukoc Biol       Date:  2016-04-22       Impact factor: 4.962

5.  Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.

Authors:  R C Budd; J C Cerottini; C Horvath; C Bron; T Pedrazzini; R C Howe; H R MacDonald
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

6.  Diverse inflammatory cytokines induce selectin ligand expression on murine CD4 T cells via p38α MAPK.

Authors:  Mark E Ebel; Olufolakemi Awe; Mark H Kaplan; Geoffrey S Kansas
Journal:  J Immunol       Date:  2015-05-04       Impact factor: 5.422

7.  Role of Ly-6A/E and T cell receptor-zeta for IL-2 production. Phosphatidylinositol-anchored Ly-6A/E antagonizes T cell receptor-mediated IL-2 production by a zeta-independent pathway.

Authors:  E K Codias; T J Fleming; C M Zacharchuk; J D Ashwell; T R Malek
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

8.  Antigen-driven effector CD8 T cell function regulated by T-bet.

Authors:  Brandon M Sullivan; Amy Juedes; Susanne J Szabo; Matthias von Herrath; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

9.  Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells.

Authors:  B K Cho; V P Rao; Q Ge; H N Eisen; J Chen
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression.

Authors:  Roberto Bellucci; Allison Martin; Davide Bommarito; Kathy Wang; Steen H Hansen; Gordon J Freeman; Jerome Ritz
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

View more
  23 in total

1.  Ly6C+ Inflammatory Monocyte Differentiation Partially Mediates Hyperhomocysteinemia-Induced Vascular Dysfunction in Type 2 Diabetic db/db Mice.

Authors:  Pu Fang 方璞; Xinyuan Li 李欣源; Huimin Shan 单慧敏; Jason J Saredy; Ramon Cueto; Jixiang Xia 夏继祥; Xiaohua Jiang 蒋晓华; Xiao-Feng Yang 杨晓峰; Hong Wang 王虹
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-01       Impact factor: 8.311

2.  Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.

Authors:  Jun Wang; Miguel F Sanmamed; Ila Datar; Tina Tianjiao Su; Lan Ji; Jingwei Sun; Ling Chen; Yusheng Chen; Gefeng Zhu; Weiwei Yin; Linghua Zheng; Ting Zhou; Ti Badri; Sheng Yao; Shu Zhu; Agedi Boto; Mario Sznol; Ignacio Melero; Dario A A Vignali; Kurt Schalper; Lieping Chen
Journal:  Cell       Date:  2018-12-20       Impact factor: 41.582

3.  IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors.

Authors:  Jonathan H DeLong; Aisling O'Hara Hall; Matt Rausch; Devapregasan Moodley; Joseph Perry; Jeongho Park; Anthony T Phan; Daniel P Beiting; Ross M Kedl; Jonathan A Hill; Christopher A Hunter
Journal:  Immunohorizons       Date:  2019-01-15

4.  Circulation of gut-preactivated naïve CD8+ T cells enhances antitumor immunity in B cell-defective mice.

Authors:  Maryam Akrami; Rosemary Menzies; Kenji Chamoto; Michio Miyajima; Ryuji Suzuki; Hiroyuki Sato; Akiko Nishii; Michio Tomura; Sidonia Fagarasan; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

5.  Toxoplasma gondii effector TgIST blocks type I interferon signaling to promote infection.

Authors:  Sumit K Matta; Philipp Olias; Zhou Huang; Qiuling Wang; Eugene Park; Wayne M Yokoyama; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-14       Impact factor: 11.205

Review 6.  The Immunobiology of the Interleukin-12 Family: Room for Discovery.

Authors:  Elia D Tait Wojno; Christopher A Hunter; Jason S Stumhofer
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

7.  Impact of Interleukin-27p28 on T and B Cell Responses during Toxoplasmosis.

Authors:  Jeongho Park; Jonathan H DeLong; James J Knox; Christoph Konradt; Elia D Tait Wojno; Christopher A Hunter
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

8.  Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Authors:  Shady Adnan-Awad; Daehong Kim; Helena Hohtari; Komal Kumar Javarappa; Tania Brandstoetter; Isabella Mayer; Swapnil Potdar; Caroline A Heckman; Soili Kytölä; Kimmo Porkka; Eszter Doma; Veronika Sexl; Matti Kankainen; Satu Mustjoki
Journal:  Leukemia       Date:  2020-11-09       Impact factor: 11.528

9.  The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent.

Authors:  Sladjana Skopelja-Gardner; Jie An; Joyce Tai; Lena Tanaka; Xizhang Sun; Payton Hermanson; Rebecca Baum; Masaoki Kawasumi; Richard Green; Michael Gale; Andrea Kalus; Victoria P Werth; Keith B Elkon
Journal:  Sci Rep       Date:  2020-05-13       Impact factor: 4.379

10.  MMP2 and TLRs modulate immune responses in the tumor microenvironment.

Authors:  Luciana R Muniz-Bongers; Christopher B McClain; Mansi Saxena; Gerold Bongers; Miriam Merad; Nina Bhardwaj
Journal:  JCI Insight       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.